Conatus Initiates Phase 2b ENCORE-PH Clinical Trial of Emricasan in Patients with NASH Cirrhosis
Nov 03, 2016 11:30 am UTC| Business
SAN DIEGO, Nov. 03, 2016 -- Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) today announced the initiation of ENCORE-PH (PH for Portal Hypertension), a randomized, double-blind, placebo-controlled, Phase 2b clinical trial...
Repligen Reports Third Quarter 2016 Financial Results
Nov 03, 2016 11:30 am UTC| Business
WALTHAM, Mass., Nov. 03, 2016 -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for the third quarter ended September 30,...
Excel Corporation Closes $25 Million Credit Facility
Nov 03, 2016 11:30 am UTC| Business
IRVING, Texas, Nov. 03, 2016 -- Excel Corporation (OTCQB:EXCC), a leading provider of integrated financial and transaction processing services to merchants throughout the United States today announced that it secured a...
MSG Networks Inc. Reports Fiscal 2017 First Quarter Results
Nov 03, 2016 11:30 am UTC| Business
Fiscal 2017 first quarter revenues of $153.6 millionFiscal 2017 first quarter operating income of $74.5 millionFiscal 2017 first quarter adjusted operating income of $78.9 million NEW YORK, Nov. 03, 2016 -- MSG...
Minerva Neurosciences Reports Third Quarter 2016 Financial Results and Business Updates
Nov 03, 2016 11:30 am UTC| Business
WALTHAM, Mass., Nov. 03, 2016 -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today...
L Brands Reports October 2016 Sales and Reiterates Third Quarter Earnings Guidance
Nov 03, 2016 11:15 am UTC| Business
COLUMBUS, Ohio, Nov. 03, 2016 -- L Brands, Inc. (NYSE:LB) reported net sales of $756.7 million for the four weeks ended Oct. 29, 2016, an increase of 3 percent, compared to net sales of $735.6 million for the four weeks...
Huntington Ingalls Industries Reports Third Quarter 2016 Results
Nov 03, 2016 11:15 am UTC| Business
Revenues were $1.68 billionTotal operating margin was 10.4%Segment operating margin was 8.3%Diluted earnings per share was $2.27Cash and cash equivalents at the end of the quarter were $957 million NEWPORT NEWS, Va., Nov....